Author Correction: Ultra-long-acting in-situ forming implants with cabotegravir protect female macaques against rectal SHIV infection

• Isabella C. Young,
• Ivana Massud,
• Mackenzie L. Cottrell,
• Roopali Shrivastava,
• Panita Maturavongsadit,
• Alka Prasher,
• Andres Wong-Sam,
• Chuong Dinh,
• Tiancheng Edwards,
• Victoria Mrotz,
• James Mitchell,
• Josilene Nascimento Seixas,
• Aryani Pallerla,
• Allison Thorson,
• Amanda Schauer,
• Craig Sykes,
• Gabriela De la Cruz,
• Stephanie A. Montgomery,
• Angela D. M. Kashuba,
• Walid Heneine,
• Charles W. Dobard,
• Martina Kovarova,
• J. Victor Garcia,
• J. Gerardo Garcίa-Lerma,
• S. Rahima Benhabbour

Affiliations

Isabella C. Young

Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill

Ivana Massud

Laboratory Branch, Division of HIV Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention

Mackenzie L. Cottrell

Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill

Roopali Shrivastava

Joint Department of Biomedical Engineering, North Carolina State University and The University of North Carolina at Chapel Hill

Panita Maturavongsadit

Joint Department of Biomedical Engineering, North Carolina State University and The University of North Carolina at Chapel Hill

Alka Prasher

Joint Department of Biomedical Engineering, North Carolina State University and The University of North Carolina at Chapel Hill

Andres Wong-Sam

Laboratory Branch, Division of HIV Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention

Chuong Dinh

Laboratory Branch, Division of HIV Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention

Tiancheng Edwards

Laboratory Branch, Division of HIV Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention

Victoria Mrotz

Comparative Medicine Branch, Division of Scientific Resources, National Center for Emerging and Zoonotic Infection Diseases, Centers for Disease Control and Prevention

James Mitchell

Laboratory Branch, Division of HIV Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention

Josilene Nascimento Seixas

Infectious Diseases Pathology Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infection Diseases, Centers for Disease Control and Prevention

Aryani Pallerla

Department of Psychology and Neuroscience, University of North Carolina at Chapel Hill

Allison Thorson

Joint Department of Biomedical Engineering, North Carolina State University and The University of North Carolina at Chapel Hill

Amanda Schauer

Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill

Craig Sykes

Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill

Gabriela De la Cruz

Pathology Services Core, Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine

Stephanie A. Montgomery

Pathology Services Core, Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine

Angela D. M. Kashuba

Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill

Walid Heneine

Laboratory Branch, Division of HIV Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention

Charles W. Dobard

Laboratory Branch, Division of HIV Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention

Martina Kovarova

International Center for the Advancement of Translational Science, Division of Infectious Diseases, Center for AIDS Research, University of North Carolina at Chapel Hill

J. Victor Garcia

International Center for the Advancement of Translational Science, Division of Infectious Diseases, Center for AIDS Research, University of North Carolina at Chapel Hill

J. Gerardo Garcίa-Lerma

Laboratory Branch, Division of HIV Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention

S. Rahima Benhabbour

Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill